Session 792: Genetic predisposition

Date: 1 February 2004, Time: 11:30 - 13:30
Location: Room 2

Oral Presentations

Time	Number	Title / Authors / Affiliations
11:30	180	P53 mutations: a novel germline aberration and a rare transversion in a supratentorial primitive neuroectodermal tumor: clinical implications. D Amikam DSc^a,d, S Davidson DSc^a, L Leshanski MSc^a, MW Ben-Arush MD^b, S Postovsky MD^b, T Peretz MD^c, A Salmon PhD MD^c, D Abeliovich PhD^c, M Sagi MD^c ^aMolecular Oncology Laboratory, Rambam Medical Center, Haifa, Jerusalem, ^bDepartment of Pediatric Hematology-Oncology Rambam Medical Center and Faculty of Medicine Technion, ^cDepartment of Human Genetics; Hadassah Hebrew University Hospital and Medical School, Tel-Hai, Jerusalem, ^dDepartment of Biotechnology and Environmental Sciences, Tel-Hai, Jerusalem, Israel
11:45	181	Multiple endocrine neoplasia type 2A – novel type of the RET gene mutation M Poturnajova, PhD Altanerova, C Altaner PhD Laboratory of Molecular Virology, Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia
12:00	182	Glutathione-S-Transferase M1 polymorphism as a susceptibility factor in development of oral lesions like leukoplakia, sub mucous fibrosis and lichen planus KC Nandipati MBBS^a, A Srivastava MS FRCS PHD MPH^a, R Ralhan PHD^b, S Chumber MS^a (a) Department of surgery. (b).Department of biochemistry, All India Institute of Medical sciences, New delhi, INDIA-110029.
12:15	183	A Loss-of-function Polymorphism in the P2X7 Receptor Gene is associated with Familial Incidence and Absence of Lymphadenopathy in CLL S Fuller MD^a, J Wiley MD^a, P Dao-Ung BSc^a, R Sluyter PhD^a, U Thunberg MD^b, G Tobin MD^b, K Skarratt BSc^a, B Gu PhD^a, S Mulligan MD^c, J Taper MD^a, R Rosenquist MD^b ^aMedicine, Sydney University, Penrith, NSW, Australia, ^bGenetics and Pathology, Uppsala University, Uppsala, Sweden, ^cHaematology, Concord Hospital, Concord, NSW, Australia
12:30	184	Hematopoietic Cell Specific Tyrosine Phosphatase: SHP1 as a Novel Biomarker of Hematopoietic Malignancies T Oka, PhD, DMS*(a); M Ouchida, PhD(b); M Koyama, MD(c); Y Nakatani, MD(a); K Hayashi, MD(a); Y Ogama, MD(d); K Takahashi, MD(a); M Tanimoto, MD(d); K Shimizu, PhD(b); T Akagi, MD(a); T Yoshino, MD(a) ^aDepartment of Pathology, ^bDepartment of Molecular Genetics, ^cDepartment of Pediatrics, ^dDepartment of Internal Medicine, Graduate School of Medicine and Dentistry; Okayama University, Okayama, Japan
12:45	185	Association between HLA B*07 and human papillomavirus related cervical cancer in Indian women. S Sengupta PhD^a, P Bhattacharya MSc^a, C Duttagupta^a Biochemistry Unit, Indian Statistical Institute, Kolkata, India

Poster Presentations

Number	Title / Authors / Affiliations
192	The nucleotide excision repair gene XPG and UVB-induced erythema. C Manson^a, L Naysmith^a, K Waterston^a, JL Rees^a, DW Melton^b ^aDermatology, University of Edinburgh, Edinburgh, United Kingdom, ^bSir Alastair Currie Cancer Research UK Labs, Molecular Medicine Centre, University of Edinburgh, Edinburgh, United Kingdom
193	Analyses of CDKN2A and CDK4 genes in sporadic melanoma patients with additional non-melanoma cancer in their family history D Pjanova *(a); O Heisele, PhD(a); L Engele, MD (b); I Desjatnikova (a) ^aBiomedical Research and Study Centre, University of Latvia, Riga, Latvia, ^bLatvian Oncological Center, Riga, Latvia
194	DNA Repair Genes Polymorphisms and Susceptibility to Familiar Breast Cancer in Portuguese and Brazilian Populations S Costa MSc^a, C Cruz SD^a, R Dufloh MD^b, F Schmitt PhD MD^c ^aLife and Health Sciences Research Institute, Health Sciences School, Minho University, Minho, Portugal, ^bCAISM, Campinas University, Brasil, Portugal, ^cInstitute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal
195	Cancer prevention in familial renal cell carcinomas: Germline analysis - strategies for risk reduction and preventive treatment HJH Decker MD^a, D Reutzel BS^a,b, E Lausch MD^b, T Liehr PhD^c, M Holl^b, S Dusterhoft^b, C Spangenberg PhD^b, D Prawitt PhD^b, B Wegner MD^d, S Naylor PhD^e, H Brauch PhD^f, B Zabel MD^b (a)Center for Human Genetics at Bioscientia Institute, Ingelheim, Germany; (b)Molecular Genetic Laboratory Children’s Hospital, Johannes-Gutenberg University Mainz, Germany; (c)Institute for Human Genetics and Anthropology, Friedrich Schiller University Jena, Germany; (d)Dept. Orthopedics, University of Rostock, Germany; (e) University of Texas Health Science Center at San Antonio Genome Center, Texas, USA (f) Dr. Margarete Fischer Bosch Institute for Clinical Pharmacology, Stuttgart, Germany
196	DNA polymorphisms and asbestos exposure in patients with malignant mesothelioma and a general population control group MD Dianzani PhD^a, L Gibello BSc^a, A Biava BSc^a, M Giordano BSc PhD^a, M Bertolotti BSc^a,b, D Mirabelli MD^b, C Magnani MD^a,b ^aDipartimento di Scienze Mediche, Università del Piemonte Orientale, Novara, Italy, ^bCPO Piemonte, Torino, Italy